 Ampio Pharmaceuticals, Inc. NYSE American: AMPE, a biopharmaceutical company focused on the development and advancement of immunology based therapies for prevalent inflammatory conditions, today announced the publication Insights into pediatric multi-system inflammatory syndrome and COVID-19. 